Literature DB >> 16446989

Virally-directed fluorescent imaging (VFI) can facilitate endoscopic staging.

P S Adusumilli1, D P Eisenberg, B M Stiles, K J Hendershott, S F Stanziale, M-K Chan, M Hezel, R Huq, V W Rusch, Y Fong.   

Abstract

BACKGROUND: Replication-competent, tumor specific herpes simplex virus NV1066 expresses green fluorescent protein (GFP) in infected cancer cells. We sought to determine the feasibility of GFP-guided imaging technology in the intraoperative detection of small tumor nodules.
METHODS: Human cancer cell lines were infected with NV1066 at multiplicities of infection of 0.01, 0.1 and 1. Cancer cell specific infectivity, vector spread and GFP signal intensity were measured by flow cytometry and time-lapse digital imaging (in vitro); and by use of a stereomicroscope and endoscope equipped with a fluorescent filter (in vivo).
RESULTS: NV1066 infected all cancer cell lines and expressed GFP at all MOIs. GFP signal was significantly higher than the autofluorescence of normal cells. One single dose of NV1066 spread within and across body cavities and selectively infected tumor nodules sparing normal tissue. Tumor nodules undetectable by conventional thoracoscopy and laparoscopy were identified by GFP fluorescence.
CONCLUSION: Virally-directed fluorescent imaging (VFI) is a real-time novel molecular imaging technology that has the potential to enhance the intraoperative detection of endoluminal or endocavitary tumor nodules.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16446989      PMCID: PMC1435379          DOI: 10.1007/s00464-005-0259-6

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  29 in total

1.  Effective treatment of head and neck squamous cell carcinoma by an oncolytic herpes simplex virus.

Authors:  R J Wong; S H Kim; J K Joe; J P Shah; P A Johnson; Y Fong
Journal:  J Am Coll Surg       Date:  2001-07       Impact factor: 6.113

2.  Laparoscopic assisted distal gastrectomy for early gastric cancer: Five years' experience.

Authors:  Erito Mochiki; Youichi Kamiyama; Ryusuke Aihara; Toshihiro Nakabayashi; Takayuki Asao; Hiroyuki Kuwano
Journal:  Surgery       Date:  2005-03       Impact factor: 3.982

3.  Laparoscopic fluorescence diagnosis for intraabdominal fluorescence targeting of peritoneal carcinosis experimental studies.

Authors:  Johannes Gahlen; Ruediger L Prosst; Matthias Pietschmann; Thomas Haase; Markus Rheinwald; Gisela Skopp; Josef Stern; Christian Herfarth
Journal:  Ann Surg       Date:  2002-02       Impact factor: 12.969

4.  Real-time optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model.

Authors:  Michael Bouvet; Jinwei Wang; Stephanie R Nardin; Rounak Nassirpour; Meng Yang; Eugene Baranov; Ping Jiang; A R Moossa; Robert M Hoffman
Journal:  Cancer Res       Date:  2002-03-01       Impact factor: 12.701

5.  Staging laparoscopy for potentially resectable noncolorectal, nonneuroendocrine liver metastases.

Authors:  M D'Angelica; W Jarnagin; R Dematteo; K Conlon; L H Blumgart; Y Fong
Journal:  Ann Surg Oncol       Date:  2002-03       Impact factor: 5.344

6.  The role of follow-up endoscopy after total gastrectomy for gastric cancer.

Authors:  S-Y Lee; J H Lee; N C Hwang; Y-H Kim; P-L Rhee; J J Kim; S W Paik; J C Rhee; T S Sohn; S Kim
Journal:  Eur J Surg Oncol       Date:  2005-04       Impact factor: 4.424

7.  Radiation therapy potentiates effective oncolytic viral therapy in the treatment of lung cancer.

Authors:  Prasad S Adusumilli; Brendon M Stiles; Mei-Ki Chan; Ting-Chao Chou; Richard J Wong; Valerie W Rusch; Yuman Fong
Journal:  Ann Thorac Surg       Date:  2005-08       Impact factor: 4.330

8.  Minimally invasive localization of oncolytic herpes simplex viral therapy of metastatic pleural cancer.

Authors:  B M Stiles; P S Adusumilli; A Bhargava; S F Stanziale; T H Kim; M-K Chan; R Huq; R Wong; V W Rusch; Y Fong
Journal:  Cancer Gene Ther       Date:  2006-01-01       Impact factor: 5.987

9.  Assessment of surgical margins in renal cell carcinoma after nephron sparing: a comparative study: laparoscopy vs open surgery.

Authors:  Francesco Porpiglia; Cristian Fiori; Carlo Terrone; Enrico Bollito; Dario Fontana; Roberto Mario Scarpa
Journal:  J Urol       Date:  2005-04       Impact factor: 7.450

10.  Effective treatment of pancreatic tumors with two multimutated herpes simplex oncolytic viruses.

Authors:  P F McAuliffe; W R Jarnagin; P Johnson; K A Delman; H Federoff; Y Fong
Journal:  J Gastrointest Surg       Date:  2000 Nov-Dec       Impact factor: 3.267

View more
  3 in total

1.  Fluorescence-assisted cytological testing (FACT): Ex Vivo viral method for enhancing detection of rare cancer cells in body fluids.

Authors:  Prasad S Adusumilli; Sepideh Gholami; Yun Shin Chun; Michael Mullerad; Mei Ki Chan; Zhenkun Yu; Leah Ben-Porat; Valerie W Rusch; Yuman Fong
Journal:  Mol Med       Date:  2011-04-08       Impact factor: 6.354

Review 2.  Herpes simplex virus 1 as an oncolytic viral therapy for refractory cancers.

Authors:  Hayle Scanlan; Zachary Coffman; Jeffrey Bettencourt; Timothy Shipley; Debra E Bramblett
Journal:  Front Oncol       Date:  2022-07-27       Impact factor: 5.738

3.  Oncolytic Herpes Simplex Virus Prevents Premalignant Lesions from Progressing to Cancer.

Authors:  Yanghee Woo; Vincent Reid; Kaitlyn J Kelly; Diane Carlson; Zhenkun Yu; Yuman Fong
Journal:  Mol Ther Oncolytics       Date:  2019-12-06       Impact factor: 7.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.